iRhythm Technologies (NASDAQ:IRTC – Get Rating) had its price objective lowered by BTIG Research from $165.00 to $140.00 in a research report released on Thursday, The Fly reports. A number of other analysts have also issued reports on the company. Morgan Stanley raised their target price on iRhythm Technologies from $128.00 to $130.00 and gave […]
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. for violations of the securities. | June 2, 2023
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. for violations of the securities. | June 1, 2023
Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC – Get Rating) have earned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and seven have assigned a buy recommendation to […]
SAN FRANCISCO, May 22, 2023 Rhythm Technologies, Inc. , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today the. | May 22, 2023